Medical devices, healthcare technology and the business of care
PMA approval · P200045

RelayPro Thoracic Stent-Graft System

Bolton Medical, Inc. · Decision date Aug 5, 2021

MEDTECHLEDGER EXPLANATIONP200045

What did the FDA approve?

The FDA database records an August 5, 2021 approval for the RelayPro Thoracic Stent-Graft System from Bolton Medical, Inc. The stated indication covers endovascular repair of fusiform aneurysms and saccular aneurysms or penetrating atherosclerotic ulcers in the descending thoracic aorta for patients with specified anatomy. Those anatomic criteria include iliac or femoral access vessel morphology compatible with vascular access techniques, devices, or accessories, and a non-aneurysmal aortic neck diameter of 20 to 42 mm.

The approval statement lists required non-aneurysmal proximal aortic neck lengths by device configuration and diameter. Bare Stent Configuration lengths range from 15 mm for 24 to 28 mm diameters to 25 mm for 40 to 46 mm diameters. Non-Bare Stent Configuration lengths are 25 mm for 24 to 38 mm diameters and 30 mm for 40 to 46 mm diameters. Distal aortic neck lengths are 25 mm for 24 to 38 mm device diameters and 30 mm for 40 to 46 mm device diameters. The record does not state clinical outcomes or comparative effectiveness.

FDA approval order statement

Approval for The RelayPro Thoracic Stent-Graft System. The device is indicated for the endovascular repair of fusiform aneurysms and saccular aneurysms/penetrating atherosclerotic ulcers in the descending thoracic aorta in patients having appropriate anatomy, including:-- Iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices, and/or accessories;-- Non-aneurysmal aortic neck diameter in the range of 20 to 42 mm; and -- Non-aneurysmal proximal aortic neck lengths of: 15 mm for the 24 to 28 mm Bare Stent Configuration device diameters 20 mm for the 30 to 38 mm Bare Stent Configuration device diameters 25 mm for the 40 to 46 mm Bare Stent Configuration device diameters 25 mm for the 24 to 38 mm Non-Bare Stent Configuration device diameters 30 mm for the 40 to 46 mm Non-Bare Stent Configuration device diameters Non-aneurysmal distal aortic neck lengths of: 25 mm for the 24 to 38 mm device diameters 30 mm for the 40 to 46 mm device diameters.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Aug 5, 2021

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P200045
Regulatory pathway
Premarket approval application
Product code
MIH
Decision code
APPR
Decision date
Aug 5, 2021
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.

Product code
MIH
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P200045 received

    Application receipt date recorded by FDA.

  2. P200045 · FDA decision

    APPR

  3. P200045/S025 · Related supplement

    RelayPro Thoracic Stent-Graft Delivery System

Timeline entries are records held by MedtechLedger for P200045. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200045

Product / regulatory recordCompanyPathwayDecision dateSource
Bolton Medical, Inc.PMA supplementOct 28, 2026FDA

Explore the linked device profile

Other records with product code MIH

Product / regulatory recordCompanyPathwayDecision dateSource
Cook, Inc.PMA supplementSep 17, 2026FDA
Cook, Inc.PMA approvalMay 23, 2003FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bolton Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
799 International Pkwy., Sunrise, FL, 33325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records